Equibles does not estimate personal net worth.
Get an email with a short summary when Arcadia Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get RKDA alertsThomas Schaefer is recorded as CEO and CFO at Arcadia Biosciences, Inc. (RKDA). The proxy statement of Arcadia Biosciences, Inc. reports total compensation of $499,477 for Thomas Schaefer in fiscal 2024, including a base salary of $260,000. Disclosed compensation is on record for 3 fiscal years. Thomas Schaefer has spoken on 1 earnings call across 1 company, most recently for Arcadia Biosciences, Inc. on May 9, 2024. Arcadia Biosciences, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Arcadia Biosciences, Inc. includes Kevin Comcowich (CEO), Rajendra Ketkar (CEO), Stan Jacot (CEO) and 7 others.
“Joining me on the call today is Stan Jacot, Arcadia's President and Chief Executive Officer.”
Packaged Foods · Consumer Defensive
CEO, CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Arcadia Biosciences, Inc. (RKDA) | CEO | $260,000 | $499,477 |
| 2023 | Arcadia Biosciences, Inc. (RKDA) | CFO | $260,000 | $380,538 |
| 2022 | Arcadia Biosciences, Inc. (RKDA) | CFO | — | — |
